Published in J Neurol Sci on January 15, 2001
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. Curr Alzheimer Res (2015) 0.75
Positional cloning of the Werner's syndrome gene. Science (1996) 10.98
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol (1998) 5.42
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology (2007) 4.24
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07
A familial Alzheimer's disease locus on chromosome 1. Science (1995) 3.14
Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science (1992) 3.14
Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology (2004) 2.83
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 2.61
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry (1996) 2.30
Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A (1999) 2.26
The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet (2000) 2.24
Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging (2005) 2.15
Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet (1987) 2.12
Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controls. Neurology (1992) 2.08
Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease. Epidemiology (2001) 1.96
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler Thromb Vasc Biol (2000) 1.94
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology (2001) 1.88
Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology (1996) 1.87
Alzheimer's disease, apolipoprotein E4, and gender. JAMA (1994) 1.86
Xylose isomerase from Escherichia coli. Characterization of the protein and the structural gene. J Biol Chem (1984) 1.82
Increased CSF cortisol in AD is a function of APOE genotype. Neurology (2001) 1.78
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science (1976) 1.76
Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology (2005) 1.75
Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology (1999) 1.72
Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol (2001) 1.69
Resolution of the multiplicity of the glutamate and aspartate transport systems of Escherichia coli. J Biol Chem (1977) 1.65
Physical and functional interaction between p53 and the Werner's syndrome protein. J Biol Chem (1999) 1.64
Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays. J Clin Pathol (2000) 1.64
Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis (2010) 1.60
DNA-triplet repeats and neurologic disease. N Engl J Med (1996) 1.60
Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann Neurol (1980) 1.59
Competent patients with advanced states of permanent paralysis have the right to forgo life-sustaining therapy. Neurology (1993) 1.58
An autosomal recessive disorder with posterior column ataxia and retinitis pigmentosa. Neurology (1997) 1.57
Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology (1995) 1.55
Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet (1996) 1.54
A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology (1999) 1.52
Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am J Hum Genet (1997) 1.52
A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord (1997) 1.51
Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology (1967) 1.50
Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology (2007) 1.48
Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord (2004) 1.48
Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol (1988) 1.47
High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry (2009) 1.45
Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. Am J Epidemiol (1997) 1.42
A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain (2007) 1.40
p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev (1999) 1.39
Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers. Am J Hum Genet (1996) 1.31
Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med (1982) 1.31
Apolipoprotein E genotype and Alzheimer's disease. Lancet (1993) 1.30
A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology (1991) 1.29
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A (1981) 1.28
Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology (1976) 1.27
Markers for gene expression in cultured cells from the nervous system. J Biol Chem (1972) 1.26
Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology (1998) 1.24
Transverse myelitis associated with heroin addiction. JAMA (1968) 1.22
A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain (1999) 1.22
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology (1995) 1.21
Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab Dispos (2001) 1.21
Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord (2000) 1.21
Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol (2001) 1.20
Homozygous and compound heterozygous mutations at the Werner syndrome locus. Hum Mol Genet (1996) 1.19
Apoptosis and neurologic disease. Am J Med (2000) 1.17
Cloning, sequencing, and mapping of the human chromosome 14 heat shock protein gene (HSPA2). Genomics (1994) 1.16
Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J Biol Chem (2000) 1.16
Mononeuritis multiplex in lepromatous leprosy. Arch Neurol (1968) 1.12
Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: a longitudinal analysis. Am J Hum Genet (1997) 1.11
A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm Genome (2001) 1.11
Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology (1997) 1.10
A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport (1999) 1.10
Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene. Hum Mutat (1998) 1.09
Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet (1996) 1.09
A family with histologically confirmed Alzheimer's disease. Arch Neurol (1983) 1.08
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry (2014) 1.07
Linkage of chromosome 13q32 to schizophrenia in a large veterans affairs cooperative study sample. Am J Med Genet (2002) 1.07
Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet (2001) 1.07
Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme. Oncogene (2011) 1.07
Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology (1971) 1.07
Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology (1987) 1.04
Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1. J Cell Biol (1999) 1.04
Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol (2000) 1.03
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology (2010) 1.02
Homozygosity mapping and Werner's syndrome. Lancet (1992) 1.02
Platelet APP isoform ratios correlate with declining cognition in AD. Neurology (2000) 1.01
Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol (1974) 1.01
Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol (2001) 1.00
The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. Arch Neurol (1999) 0.99
parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease. Am J Med Genet A (2004) 0.99
Neurological complications of fibrous dysplasia of the skull. Arch Neurol (1968) 0.99
Molecular evidence of clonality amongst Vibrio cholerae O1 biotype El Tor during an outbreak in Malaysia. Epidemiol Infect (2000) 0.99
The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology (1999) 0.98
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea. Clin Cancer Res (2000) 0.98
Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol (1978) 0.97
The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97
Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines. J Neurol Neurosurg Psychiatry (1985) 0.97
Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol (1978) 0.97